V022-3445 Screening compound: N-[(2-methylphenyl)methyl]-N-(4-{[(1-phenylethyl)carbamoyl]methyl}phenyl)cyclopentanecarboxamide

V022-3445 Screening compound: N-[(2-methylphenyl)methyl]-N-(4-{[(1-phenylethyl)carbamoyl]methyl}phenyl)cyclopentanecarboxamide
V022-3445 Screening compound: N-[(2-methylphenyl)methyl]-N-(4-{[(1-phenylethyl)carbamoyl]methyl}phenyl)cyclopentanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-3445
N-[(2-methylphenyl)methyl]-N-(4-{[(1-phenylethyl)carbamoyl]methyl}phenyl)cyclopentanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-3445

Molecular Formula

C30H34N2O2 (C30 H34 N2 O2)

Compound Name

N-[(2-methylphenyl)methyl]-N-(4-{[(1-phenylethyl)carbamoyl]methyl}phenyl)cyclopentanecarboxamide

IUPAC name

N-[(2-methylphenyl)methyl]-N-(4-{[(1-phenylethyl)carbamoyl]methyl}phenyl)cyclopentanecarboxamide

SMILES

CC(c1ccccc1)NC(Cc(cc1)ccc1N(Cc1c(C)cccc1)C(C1CCCC1)=O)=O

InChI

InChI=1S/C30H34N2O2/c1-22-10-6-7-15-27(22)21-32(30(34)26-13-8-9-14-26)28-18-16-24(17-19-28)20-29(33)31-23(2)25-11-4-3-5-12-25/h3-7,10-12,15-19,23,26H,8-9,13-14,20-21H2,1-2H3,(H,31,33)/t23-/m0/s1

InChI Key

FXXRBLVYAFZRAV-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19910555

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.61

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.078

Distribution Coefficient, logD

6.078

Water Solubility, LogSw

-5.36

Polar Surface Area

39.511

Acid Dissociation Constant (pKa)

12.56

Base Dissociation Constant (pKb)

-1.10

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

V022-3445 in Drug Discovery

Included in Screening Libraries

Glucocorticoid receptors Library (4806 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V022-3445 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-3445?
Check Price and Availability of V022-3445, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-3445 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-3445
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-3445
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-3445 available by request